Recursion Pharmaceuticals Inc (RXRX)
5.70
-0.05
(-0.87%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.05
(+0.88%)
After-Hours: 20:00
Recursion Pharmaceuticals Stock Buybacks (Quarterly): -16.97M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -16.97M |
| June 30, 2024 | -261.55M |
| March 31, 2024 | -10.87M |
| December 31, 2023 | -78.09M |
| September 30, 2023 | -50.00M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -143.71M |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -462.90M |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-462.90M
Minimum
Jun 2021
--
Maximum
Jun 2020
-68.27M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
| Revance Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -2.858M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.004M |
| Theriva Biologics Inc | -3.716M |